Evidence map›Paper›PMID 37144091›Full record

ArticleFrontiers in neuroscience2023

Editorial: Sleep and circadian rhythm disruptions associated with substance use disorders.

Lais F Berro, Rodrigo A España, Jessica A Mong, Robert W Gould

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Lais F BerroDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, United States.
Rodrigo A EspañaDepartment of Neurobiology and Anatomy, College of Medicine, Drexel University, Philadelphia, PA, United States.
Jessica A MongDepartment of Pharmacology, University of Maryland, Baltimore, MD, United States.
Robert W GouldDepartment of Physiology and Pharmacology, School of Medicine, Wake Forest University, Winston-Salem, NC, United States.
Drexel University · USUniversity of Maryland, Baltimore · USUniversity of Mississippi Medical Center · USWake Forest University · US

Funding

Characterization, optimization, and development of dual mGlu2/3 positive allosteric modulators for opioid use disorderR01DA057120 · NIDA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI COSFORD, NICHOLAS DAVID, GOULD, ROBERT WARREN · 2022 to 2022
$6.4M
Partial mGlu5 Negative Allosteric Modulators to Prevent Relapse to Cocaine AbuseR00DA042129 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GOULD, ROBERT WARREN · 2019 to 2021
$747k
NIDA NIH HHS R00 DA042129NIDA NIH HHS R01 DA057120
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alcohol use disorder (AUD)circadian rhythm disruptionspreclinical modelsleep disruptionssubstance use disorder (SUD)

Identifiers

PMID37144091
PMCPMC10151812
OpenAlexW4366290664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.